Citigroup Has Lowered Expectations for Waystar (NASDAQ:WAY) Stock Price

Waystar (NASDAQ:WAY) had its price objective lowered by Citigroup from $35.00 to $30.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price suggests a potential upside of 44.11% from the company’s previous close.

A number of other analysts have also recently weighed in on the stock. The Goldman Sachs Group decreased their target price on shares of Waystar from $44.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, February 18th. Leerink Partners assumed coverage on Waystar in a research note on Monday, February 2nd. They issued an “outperform” rating and a $43.00 price target for the company. Raymond James Financial reissued a “strong-buy” rating and set a $32.00 price objective on shares of Waystar in a report on Thursday. UBS Group reduced their price objective on Waystar from $41.00 to $37.00 and set a “buy” rating on the stock in a research report on Thursday, April 30th. Finally, Barclays lowered their target price on Waystar from $42.00 to $36.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Three investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Waystar presently has an average rating of “Moderate Buy” and an average target price of $36.14.

Waystar Price Performance

NASDAQ WAY traded down $0.06 during trading on Tuesday, hitting $20.82. 516,654 shares of the company’s stock were exchanged, compared to its average volume of 2,645,486. The company has a market cap of $3.99 billion, a PE ratio of 31.09, a P/E/G ratio of 0.80 and a beta of 0.21. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37. Waystar has a fifty-two week low of $20.35 and a fifty-two week high of $42.55. The stock’s 50 day moving average price is $24.57 and its two-hundred day moving average price is $29.65.

Waystar (NASDAQ:WAY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.03. The company had revenue of $313.87 million for the quarter, compared to the consensus estimate of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period last year, the company posted $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Research analysts expect that Waystar will post 1.46 EPS for the current year.

Hedge Funds Weigh In On Waystar

A number of hedge funds have recently modified their holdings of the business. Salomon & Ludwin LLC bought a new stake in shares of Waystar in the third quarter worth $25,000. Root Financial Partners LLC raised its position in Waystar by 6,475.0% during the 1st quarter. Root Financial Partners LLC now owns 1,052 shares of the company’s stock worth $25,000 after purchasing an additional 1,036 shares during the last quarter. ANTIPODES PARTNERS Ltd raised its position in Waystar by 120.1% during the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock worth $31,000 after purchasing an additional 449 shares during the last quarter. First Horizon Corp acquired a new position in Waystar during the 3rd quarter worth about $38,000. Finally, Smartleaf Asset Management LLC lifted its holdings in Waystar by 6,005.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company’s stock worth $38,000 after buying an additional 1,141 shares during the period.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.